APTV vs PPCB · P/E 41, rev $19.71B vs P/E 0.0, $3.9M cap
Aptiv PLC (APTV) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
PPCB does not have a complete income-statement cache yet.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the APTV and PPCB stock pages for the full models.
Not investment advice.